Covid-19 Response

Read more

Reports and statements Biosciences

Healthcare-associated infections: the view from EASAC

Healthcare-associated infections are an increasing problem for the European Union. Many Member States are spending a substantial proportion of their healthcare budget on these infections, which affect about 7% of patients in acute care hospitals. The problem is compounded by the decreasing clinical effectiveness of antibiotics because of the spread of bacterial resistance.

Download

back to overview